Payal Rabde, a Healthcare Industry Expert, highlights that the cancer tumor profiling market has reached USD 17.71 billion in 2026 and is on track to reach USD 48.33 billion by 2035, advancing at a CAGR of 11.80%. Key cancer tumor profiling market companies shaping the market include Thermo Fisher Scientific, Illumina, Exact Sciences, while major growth segments span technology, cancer type, process type, application and region.
